1. Home
  2. PRAX vs CAMT Comparison

PRAX vs CAMT Comparison

Compare PRAX & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$288.69

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Logo Camtek Ltd.

CAMT

Camtek Ltd.

N/A

Current Price

$152.34

Market Cap

7.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
CAMT
Founded
2015
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
7.4B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
PRAX
CAMT
Price
$288.69
$152.34
Analyst Decision
Strong Buy
Buy
Analyst Count
19
12
Target Price
★ $638.68
$184.00
AVG Volume (30 Days)
★ 357.8K
279.3K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.57
Revenue Next Year
$39,590.54
$25.48
P/E Ratio
★ N/A
$155.63
Revenue Growth
N/A
★ N/A
52 Week Low
$50.31
$91.91
52 Week High
$392.70
$215.99

Technical Indicators

Market Signals
Indicator
PRAX
CAMT
Relative Strength Index (RSI) 35.63 59.20
Support Level $282.35 $143.41
Resistance Level $354.17 $161.14
Average True Range (ATR) 14.63 5.15
MACD -1.65 1.71
Stochastic Oscillator 21.96 97.60

Price Performance

Historical Comparison
PRAX
CAMT

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Chiplets, HBM, Compound Semiconductors, Memory, CMOS Image Sensors, Power, RF and MEMS, serving the industry's IDMs, OSATs, and foundries. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: